During the past decade, East Bay Radiation Oncology Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 58 clinical trials were completed, i.e. on average, 2900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 15 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Bay Radiation Oncology Center" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "Radiation Therapy Oncology Group" with 5 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Bay Radiation Oncology Center" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "East Bay Radiation Oncology Center" are "Breast Cancer" (16 trials), "Lung Cancer" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Prostate Cancer" (6 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "East Bay Radiation Oncology Center" in a lesser frequency.

Most popular intervention types in "East Bay Radiation Oncology Center" are "Drug" (71 trials), "Other" (45 trials), "Biological" (31 trials), "Radiation" (19 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Bevacizumab" (16 trials), "Paclitaxel" (13 trials), "Quality-of-Life Assessment" (13 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "East Bay Radiation Oncology Center" are 55 trials for "All" genders, 25 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "East Bay Radiation Oncology Center". undefined are not yet recruiting, 1 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in East Bay Radiation Oncology Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in East Bay Radiation Oncology Center, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".